EPL's Indovida merger clears the competition regulator.
The CCI's no-objection removes a key condition precedent for the absorption deal announced in March. The scheme still needs other clearances to become effective.
— 1 earlier story on EPL Ltd. →What's new
- Competition Commission of India gave its no-objection to EPL's merger with Indovida India on May 26.
- This removes a major condition precedent for the absorption deal first approved by EPL's board on March 29, 2026.
- The merger still requires other statutory and regulatory approvals before it becomes effective.
Why this matters
A competition clearance is a mandatory gate for any merger of this scale. Crossing it removes a concrete source of deal uncertainty. The lack of any change in terms or new financial impact keeps this as a procedural step, not a valuation event.
What we're watching
- The detailed CCI order, which has not yet been issued.
- Timelines for the remaining statutory approvals, including from the NCLT and stock exchanges.
- Any revised timeline for the scheme's effective date.
The full read
EPL has cleared a major hurdle. The Competition Commission of India issued its no-objection on May 26, moving the March 29-announced deal past a mandatory regulatory checkpoint. For a ₹7,014 crore company, this is important. It is not, however, the finish line. The merger still requires other statutory approvals, and the detailed CCI order is yet to be published. The market had anticipated this progression. What changes from here is the focus shifts to the remaining clearances.
Questions answered
- What did the CCI actually approve?
- The CCI conveyed a no-objection under Section 31(1) of the Competition Act for EPL to absorb Indovida India. The detailed order explaining its reasoning is still awaited.
- How long has this merger been in the works?
- The scheme of amalgamation was first approved by EPL's board on March 29, 2026. The CCI clearance came just under two months later.
- Is the merger now final?
- No. The CCI clearance removes one major condition precedent, but the deal remains subject to other statutory and regulatory approvals, including from the NCLT.
- Did the filing change the deal's terms?
- No. The announcement discloses no changes to the merger terms or any new financial impact. It is a procedural update on a previously announced transaction.
EPL Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on EPL →- 27 May 2026 · 5:46 PM IST EPL's Indovida merger clears the competition regulator.
- 47d ago EPL's transcript: Cost pass-through confidence, Indovida merger on track